C2i Genomics Ltd.

c2i-genomics.com

Now C2i Genomics (a Veracyte company)

High-Tech Company

Acquired by Veracyte

TAGS

Analysis, Artificial Intelligence, Cancer, Cloud, Diagnostics, Genomics, Monitoring, SaaS, Signal Processing

General Data

Sector	Life Sciences
Sub-Sector	Biotechnology

TECHNOLOGY

C2i’s liquid biopsy is a robust tool for cancer tumor monitoring. It is the first to work by identifying subtle changes in genetic patterns across the entire tumor. Based on advanced bioinformatics and AI, it compares numerous data points o...(Unlock More)...

CONTACT INFO

Personal Contact Information

Blog

Expand / Collapse All

	MANAGEMENT

Key Executive

	BOARD

Board

	FINANCIAL ROUNDS

Round

Date

Stage

Amount

Valuation

Second Round

Apr. 15, 2021

R&D

$100m

N/A

General Info

Angel Company & Title
E-mail
Website
No. of Current Portfolio Companies
Remarks

Business Description

Description
Angel Activity

Investment Data

Managed Capital
Capital Remarks
Capital Available

Preferences

Maximum investments
Minimum investments
Type of Financing
Stage Preferences
Phase Preferences
Industry Preferences

	SECTOR SEGMENTATION (By Number Of Companies)

Current Israeli Clients (#)

	Deals Underwritten (#)

	Deals Legally Advised (#)

	Current Positions

	Previous Positions

	Background

	Education

	Specialties

Last Updated: Jan 09, 2024